Literature DB >> 12454307

Chlamydia pneumoniae and COPD exacerbation.

T A R Seemungal, J A Wedzicha, P K MacCallum, S L Johnston, P A Lambert.   

Abstract

Mesh：

Year:  2002        PMID： 12454307      PMCID： PMC1758790          DOI： 10.1136/thorax.57.12.1087-a

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  15 in total

Review 1.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

2.  Markers of exacerbation severity in chronic obstructive pulmonary disease.

Authors:  Luigi G Franciosi; Clive P Page; Bartolome R Celli; Mario Cazzola; Michael J Walker; Meindert Danhof; Klaus F Rabe; Oscar E Della Pasqua
Journal:  Respir Res       Date:  2006-05-10

3.  Relationship Among Chlamydia and Mycoplasma Pneumoniae Seropositivity, IKZF1 Genotype and Chronic Obstructive Pulmonary Disease in A General Japanese Population: The Nagahama Study.

Authors:  Shigeo Muro; Yasuharu Tabara; Hisako Matsumoto; Kazuya Setoh; Takahisa Kawaguchi; Meiko Takahashi; Isao Ito; Yutaka Ito; Kimihiko Murase; Chikashi Terao; Shinji Kosugi; Ryo Yamada; Akihiro Sekine; Takeo Nakayama; Kazuo Chin; Michiaki Mishima; Fumihiko Matsuda
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  High Seroprevalence of Bordetella pertussis in Patients with Chronic Obstructive Pulmonary Disease: A Case-Control Study.

Authors:  Seyyed Hamid Hashemi; Ebrahim Nadi; Mehrdad Hajilooi; Mohammad-Ali Seif-Rabiei; Atefeh Samaei
Journal:  Tanaffos       Date:  2015

Review 5.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

6.  Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.

Authors:  Hanaa Ahmed Shafiek; Nashwa Hassan Abd-Elwahab; Manal Mohammad Baddour; Mohamed Mabrouk El-Hoffy; Akram Abd-Elmoneim Degady; Yehia Mohamed Khalil
Journal:  ISRN Microbiol       Date:  2012-06-21

7.  Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice.

Authors:  Francesco Blasi; Stefano Aliberti; Luigi Allegra; Gioia Piatti; Paolo Tarsia; Jacobus M Ossewaarde; Vivienne Verweij; Frans P Nijkamp; Gert Folkerts
Journal:  Respir Res       Date:  2007-11-19

8.  A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease.

Authors:  Eskandarain Shafuddin; Graham D Mills; Mark D Holmes; Phillippa J Poole; Peter R Mullins; Peter N Black
Journal:  J Negat Results Biomed       Date:  2015-09-07

9.  Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Ho Ii Yoon; Chang-Hoon Lee; Deog Kyeom Kim; Geun Min Park; Sang-Min Lee; Jae-Joon Yim; Jae-Yeol Kim; Jae Ho Lee; Choon-Taek Lee; Hee Soon Chung; Young Whan Kim; Sung Koo Han; Chul-Gyu Yoo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-07-10

10.  Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.

Authors:  Tom M A Wilkinson; John R Hurst; Wayomi R Perera; Mark Wilks; Gavin C Donaldson; Jadwiga A Wedzicha
Journal:  Chest       Date:  2006-02       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.